[The mechanisms of action of etophylline-clofibrate in hyperlipidemia]. 1993

I Păduraru, and M Nechifor, and G Dănilă, and L Jercă, and M Filip, and A Iacobovici, and E Teslaru, and C Filip, and A Saramet
Disciplina de Biochimie, Universitatea de Medicină şi Farmacie Iaşi.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008297 Male Males
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000960 Hypolipidemic Agents Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. Antihyperlipidemic,Antilipemic,Antilipemic Agents,Antilipemic Drug,Hypolipidemic Agent,Hypolipidemic Drug,Antihyperlipemics,Antihyperlipidemics,Antilipemic Drugs,Antilipemics,Hypolipidemic Drugs,Agent, Hypolipidemic,Agents, Antilipemic,Agents, Hypolipidemic,Drug, Antilipemic,Drug, Hypolipidemic,Drugs, Antilipemic,Drugs, Hypolipidemic
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D013806 Theophylline A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. 1,3-Dimethylxanthine,3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione,Accurbron,Aerobin,Aerolate,Afonilum Retard,Aquaphyllin,Armophylline,Bronchoparat,Bronkodyl,Constant-T,Elixophyllin,Euphylong,Glycine Theophyllinate,Lodrane,Monospan,Nuelin,Nuelin S.A.,Quibron T-SR,Slo-Phyllin,Somophyllin-T,Sustaire,Synophylate,Theo Von Ct,Theo-24,Theo-Dur,Theobid,Theocin,Theoconfin Continuous,Theodur,Theolair,Theolix,Theon,Theonite,Theopek,Theophylline Anhydrous,Theophylline Sodium Glycinate,Theospan,Theostat,Theovent,Uniphyl,Uniphyllin,Uniphylline,1,3 Dimethylxanthine,Anhydrous, Theophylline,Constant T,ConstantT,Ct, Theo Von,Glycinate, Theophylline Sodium,Quibron T SR,Quibron TSR,Slo Phyllin,SloPhyllin,Sodium Glycinate, Theophylline,Somophyllin T,SomophyllinT,Theo 24,Theo Dur,Theo24,Theophyllinate, Glycine,Von Ct, Theo

Related Publications

I Păduraru, and M Nechifor, and G Dănilă, and L Jercă, and M Filip, and A Iacobovici, and E Teslaru, and C Filip, and A Saramet
July 1972, Journal of lipid research,
I Păduraru, and M Nechifor, and G Dănilă, and L Jercă, and M Filip, and A Iacobovici, and E Teslaru, and C Filip, and A Saramet
April 1985, Atherosclerosis,
I Păduraru, and M Nechifor, and G Dănilă, and L Jercă, and M Filip, and A Iacobovici, and E Teslaru, and C Filip, and A Saramet
April 1995, Vnitrni lekarstvi,
I Păduraru, and M Nechifor, and G Dănilă, and L Jercă, and M Filip, and A Iacobovici, and E Teslaru, and C Filip, and A Saramet
October 1995, Atherosclerosis,
I Păduraru, and M Nechifor, and G Dănilă, and L Jercă, and M Filip, and A Iacobovici, and E Teslaru, and C Filip, and A Saramet
June 1979, Harefuah,
I Păduraru, and M Nechifor, and G Dănilă, and L Jercă, and M Filip, and A Iacobovici, and E Teslaru, and C Filip, and A Saramet
January 1969, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
I Păduraru, and M Nechifor, and G Dănilă, and L Jercă, and M Filip, and A Iacobovici, and E Teslaru, and C Filip, and A Saramet
December 1977, Clinical nephrology,
I Păduraru, and M Nechifor, and G Dănilă, and L Jercă, and M Filip, and A Iacobovici, and E Teslaru, and C Filip, and A Saramet
September 1978, JPMA. The Journal of the Pakistan Medical Association,
I Păduraru, and M Nechifor, and G Dănilă, and L Jercă, and M Filip, and A Iacobovici, and E Teslaru, and C Filip, and A Saramet
February 1977, The Journal of laboratory and clinical medicine,
I Păduraru, and M Nechifor, and G Dănilă, and L Jercă, and M Filip, and A Iacobovici, and E Teslaru, and C Filip, and A Saramet
November 1976, Die Medizinische Welt,
Copied contents to your clipboard!